secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001193125-23-277418
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health hit with $83.4M patent infringement verdict; will appeal
------------------------------------------------------------------------

- Jury found willful infringement of two patents; awarded $83.4M in damages (6% royalty on past sales).
- Plaintiffs may seek up to treble damages (≈$250M) based on the willfulness finding.
- Guardant strongly disagrees, plans post-trial motions and appeal to Federal Circuit.
- Company says verdict unlikely to materially impact business but may require future royalty payments if upheld.
- Case: TwinStrand Biosciences, Inc. and Univ. of Washington v. Guardant Health, C.A. No. 21-1126-GBW-SRF.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523277418/0001193125-23-277418-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523277418/d850613d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277418

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer